H7 BioCapital’s Post

🚀 Meet Our Advisors! We are excited to highlight that Neil Littman, Founding Partner of Bioverge Ventures and Partner of Riverine Ventures, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 20th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 20th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Neil Littman "Neil Littman, M.S. is Founder & CEO of Bioverge Ventures, a venture capital firm exclusively dedicated to investing in #earlystage, #cuttingedge #healthcare companies. Bioverge’s investment thesis is focused on companies spanning the intersection of health + tech that are utilizing advances in technology to modernize healthcare, from bench-to-bedside." "Previously, Neil was Vice President of Business Development at Notable Labs, an oncology startup and Bioverge portfolio company, where he led the development of global corporate partnerships and contributed to the strategic vision of Notable as part of the Senior Leadership Team. Neil oversaw business development at Notable through the successful completion of the company’s $40 million Series B and was instrumental in negotiating multiple terms sheets to in-license clinical stage oncology assets." 🌷Apply now to learn invaluable insights from Neil Littman get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales

Leading Two Boston Life Sciences VC Panels Next Week Next Thursday, I will be leading two panels in Cambridge, MA: one on preparing for an initial life sciences VC/CVC capital raise, and the other on Boards of Directors/Advisers for startup life sciences ventures. These are private panels, however, not open to the public. (They are part of a 2-week "immersion" in the Boston life sciences ecosystem.) For these two in-person panels, I have recruited a partner at Takeda Ventures, the CEO of Xontogeny Ventures, a Principal at MPM BioImpact Fund, and the founder and Board member of LabShares Newton, a local life sciences startup incubator. Looking forward to visiting Boston once again! #venturecapital, #venture, #lifesciences, #biotech, #pharma, #healthcare, #medicaldevices, #startups, #funding, #investing #startup, #lifesciences, #seedcapital, #seedfunding, #angelinvestment, #angel, #angelinvesting

Venture capitals can help drive drug development, particularly for startups and early-stage biotechs. 💸 As most focus on raising funds to expand research and development, some play a significant role in launching life science companies and bringing their products to the clinic. 🏥 They can recruit expertise, form strategic alliances, in efforts to move drug candidates to the clinic, hoping they eventually hit the market. 🚀 Labiotech spoke to Johan Kördel, Managing Partner at Sound Bioventures and Stewart Dixon, Founder and Managing Partner of VentureDNA, to discuss the role of VCs in building biotechs and accelerating clinical progress. 📈 Read our latest article to find out how VCs can play a major role in the development of early-stage biotechs! 👇 https://lnkd.in/dRiC9Seq #venturecapital #biotechstartups #drugdevelopment #lifesciences #startupfunding #earlystagebiotech #clinicaldevelopment #strategicalliances #biotechinvestment

Investors in #Boston and #NewEngland driving life sciences #innovation These local VC firms and angel groups investing in the future of healthcare and life sciences: Borealis Ventures Borealis Ventures partners with healthcare visionaries to build impactful companies, guiding startups from early stages through to growth. They bring expertise and networks to address critical healthcare needs. Hub Angels Investment Group Hub Angels Investment Group, a longstanding Boston angel group, has supported over 50 young tech and life science companies since 2000. With more than $50M invested, they’re committed to empowering diverse founders across sectors like mobile, life sciences, and software. Launchpad Venture Group As the largest angel group in the Northeast, Launchpad Venture Group actively invests in early-stage life science and high-tech startups, bringing together Boston-area experts and entrepreneurs. Maine Venture Fund (MVF) MVF champions Maine-based startups with high growth and local economic impact potential, typically providing $100-200K in funding. MVF works closely with other investors and fosters growth through initiatives like the Maine Startup Challenge. Mass Medical Angels (MA2) Focused on early-stage life sciences, MA2 supports capital-efficient companies needing $250K to $3M in funding. They bring funds and mentorship, helping to foster the Boston area’s medical innovation ecosystem. Vida Ventures, LLC Founded by scientists, physicians, and investors passionate about biomedical breakthroughs, Vida Ventures manages $1.8 billion to fund transformative biomedicine with the potential to make a difference for patients. 📈 Discover these and more VC firms in the Startup Boston Investor Directory right here: https://lnkd.in/eKRuWSzb #LifeSciences #BostonInvestors #StartupBoston

🚀 Meet Our Advisors! We are excited to highlight that Nola E. Masterson, Venture Partner at Portfolia, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Nola E. Masterson "Nola has over 40 years of experience building and supporting biotech companies as an investor, entrepreneur, and consultant. She currently funds biotech ventures through Portfolia Femtech Funds. Her extensive background and commitment to advancing biotech innovation make her a key player in the industry." 🌷Apply now to learn invaluable insights from Nola E. Masterson and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel

🚀 Meet Our Advisors! We are excited to highlight that Nola E. Masterson, Venture Partner at Portfolia, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Nola E. Masterson "Nola has over 40 years of experience building and supporting biotech companies as an investor, entrepreneur, and consultant. She currently funds biotech ventures through Portfolia Femtech Funds. Her extensive background and commitment to advancing biotech innovation make her a key player in the industry." 🌷Apply now to learn invaluable insights from Nola E. Masterson and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel

Encouraging Signs for Medtech VC in Q1 2024 🚀 #medtech #venturecapital The medtech venture capital market roared back to life in the first quarter of 2024, with total investment reaching $3.3 billion according to the latest data from PitchBook. While deal volume remained historically low, this figure represents a strong rebound as investors piled into high-quality companies, signaling a keen focus on backing the most promising opportunities. #startup #funding The largest deal went to early cancer detection startup Freenome, which raised an impressive $254 million late-stage round led by Roche Venture Fund and Bain Capital Life Sciences. Other notable investments in the quarter included rounds for Impulse Dynamics, Mainstay Medical, Alamar Biosciences, and Medical Microinstruments. #biotechnology #oncology At $3.3 billion invested, Q1 2024 saw medtech VC activity reach a level not witnessed since Q4 2022 - providing a much-needed shot of optimism after a challenging few years for fundraising in the sector. However, it still lags behind the quarterly highs above $6 billion seen in 2021 during the VC boom years. #investment #venturecapital Looking at the overall landscape, Chicago's Tempus tops the list of top VC-backed medtech companies tracked by PitchBook, having raised a staggering $1.4 billion to date. #startups #entrepreneurs Read more: https://bit.ly/4dZoHH6

We celebrated the achievements of our first BioAccelerate graduates yesterday, acknowledging their progress and growth over the last 6 months. In intensive bi-monthly sessions, participants and their mentors: 📝 Refined their business strategy 🎯 Set goals 📈 Achieved significant milestones "[BioAccelerate] and other activities have given me a broad and fast-tracked sweep into early-stage biotech. Simply put, I am a better CEO than I was even a few months ago for having participated in the program" - David Bibby, CEO of Pacalis Therapeutics Pty Ltd, mentored by Tamara Mills. "Mentoring and having the right advice are just as crucial as capital raising. Without demonstrating effective fund allocation, you won't secure the capital needed to grow your business. For early-stage businesses and first-time entrepreneurs, invaluable wisdom comes from experienced mentors and Board members." - Christos Papadimitriou, CEO of Tessara Therapeutics, mentored by Stephane Chatonsky. Congratulations to David and Christos on completing the BioAccelerate program under the exceptional guidance of their respective mentors, Tamara and Stephane 👏 We look forward to witnessing their continued growth and impact on the future of Australia's biotech industry. #JumarBioincubator #BiotechInnovation #biotech #startups #innovation #incubator

Only 2️⃣ weeks left until our “Life Sciences start-ups meet Investors” event! 𝗧𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝘀 𝗱𝗲𝘀𝗶𝗴𝗻𝗲𝗱 𝘁𝗼 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝘀𝘁𝗮𝗿𝘁-𝘂𝗽𝘀 𝘄𝗶𝘁𝗵 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀: ⚡ Discover how you can accelerate your entrepreneurial journey as a founder by attending a keynote and panel discussion led by industry leaders and networking directly with them! 💡 "𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗯𝗮𝗿𝗿𝗶𝗲𝗿𝘀: 𝗛𝗼𝘄 𝘁𝗼 𝗼𝘃𝗲𝗿𝗰𝗼𝗺𝗲 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗶𝗻 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝘀𝘁𝗮𝗿𝘁-𝘂𝗽𝘀", will be the topic of the keynote and the panel discussion. 🔝 Keynote speaker Marcus Peiker, Platform Development Specialist at Sartorius, will provide insights into 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗮𝗻𝗱 𝘃𝗲𝗻𝘁𝘂𝗿𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹. Sonali Müller, Program Manager, Start2 Group, will moderate the panel discussion, which will feature a variety of speakers with different perspectives, including: ▶️ Jonas Ide (Investment Manager, Evonik Ventures) - 𝗿𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝗰𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗲 𝘃𝗲𝗻𝘁𝘂𝗿𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 ▶️ Amy K. (VC Investor, TVM Capital Life Science) - sharing insights 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗩𝗖 𝘄𝗼𝗿𝗹𝗱 ▶️ Noah Vogt (Business Development Manager Central Europe, Sartorius) - bringing 𝘁𝗵𝗲 𝘃𝗶𝗲𝘄 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗲𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺 ▶️ Pascal Lindemann (Co-founder & CEO, Lime Medical) - providing the 𝘀𝘁𝗮𝗿𝘁-𝘂𝗽 𝗳𝗼𝘂𝗻𝗱𝗲𝗿'𝘀 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 Although the pitch deadline has passed, there are still a 𝗹𝗶𝗺𝗶𝘁𝗲𝗱 𝗻𝘂𝗺𝗯𝗲𝗿 𝗼𝗳 𝗽𝗹𝗮𝗰𝗲𝘀 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 👉 https://lnkd.in/esDZpJ9H We thank our sponsor Sartorius and our community partner Nucleate Germany for their invaluable support. We're also thrilled to have so many innovative startups and leading VCs join us! We can’t wait to see you there! #healthcare #digitalhealth #lifesciences #venturecapital #startups Philipp Gerbert, Maria Sievert, Felicitas Eidenschink, Josef Braun, Franziska Mandl, Laurin S. Waldmann, Hannes Weiland, Chiara Canavesi, Matthias Notz, Marius Rosenberg, Stefan B. Beerhalter (German Accelerator) 

Germany-based Earlybird Venture Capital Health recently successfully concluded the final closing of its second fund. 💸 Final close of its €173m (£147.6m) backed by major European institutional investors including health insurers, strategic investors, and public and private organisations. €20m was committed from British Patient Capital. 💡’Healthcare sectors, with an emphasis on #digitalhealth, diagnostics, medical devices, research and development tools and #biopharma.’ 🌍 The fund is targeting European startups. 📈 ‘This fund is more than twice the size of Earlybird’s first healthcare-focused fund, Health I, which reached €85 million at its final closing.’ 💭 “Innovation in the #UK is second to none and is underpinned by world-class science…we are committed to supporting the European startup ecosystem and fostering the development and growth of some of the world’s most exciting new companies who stand to positively impact the lives of millions of people across the globe in the future.” - John Yianni, partner, Earlybird Health. 🗞️Oscar Hornstein UKTN https://lnkd.in/eCnHfwwN 👏 For the #AudaciousInvestors unleashing innovation and empowering tomorrow🚀 Roland Manger I John Yianni I Rabab Nasrallah, I Junkai Z. I Dr. Marie-Thérèse Buttlar I Thom Rasche I Lionel Carnot I Rainer Christine I Florent Gros I Dr. Christoph Massner I Christine Hockley I Team Earlybird Health … #venturecapital #vc #funds #startups #entrepreneurs #funding #tech #entrepreneurship #technology #innovation #healthtech #europe